941 related articles for article (PubMed ID: 22301798)
1. The secret ally: immunostimulation by anticancer drugs.
Galluzzi L; Senovilla L; Zitvogel L; Kroemer G
Nat Rev Drug Discov; 2012 Feb; 11(3):215-33. PubMed ID: 22301798
[TBL] [Abstract][Full Text] [Related]
2. Recombinant viral vaccines for cancer.
Cawood R; Hills T; Wong SL; Alamoudi AA; Beadle S; Fisher KD; Seymour LW
Trends Mol Med; 2012 Sep; 18(9):564-74. PubMed ID: 22917663
[TBL] [Abstract][Full Text] [Related]
3. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
[TBL] [Abstract][Full Text] [Related]
4. Antitumour immune response and cancer vaccination: the critical role of dendritic cells.
Kochman S; Bernard J
Curr Med Res Opin; 1999; 15(4):321-6. PubMed ID: 10640266
[TBL] [Abstract][Full Text] [Related]
5. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.
Emens LA; Jaffee EM
Cancer Res; 2005 Sep; 65(18):8059-64. PubMed ID: 16166275
[TBL] [Abstract][Full Text] [Related]
6. The identification of cancer antigens: impact on the development of cancer vaccines.
Rosenberg SA
Cancer J; 2000 Apr; 6 Suppl 2():S142-9. PubMed ID: 10803829
[No Abstract] [Full Text] [Related]
7. Immunological aspects of cancer chemotherapy.
Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G
Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448
[TBL] [Abstract][Full Text] [Related]
8. Genetically modified tumour vaccines--where we are today.
Nawrocki S; Mackiewicz A
Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
[TBL] [Abstract][Full Text] [Related]
9. Cancer vaccination progress.
Pawelec G; Rees RC
Trends Mol Med; 2002 Dec; 8(12):545-6. PubMed ID: 12470983
[TBL] [Abstract][Full Text] [Related]
10. Translating tumor antigens into cancer vaccines.
Buonaguro L; Petrizzo A; Tornesello ML; Buonaguro FM
Clin Vaccine Immunol; 2011 Jan; 18(1):23-34. PubMed ID: 21048000
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.
Zitvogel L; Galluzzi L; Smyth MJ; Kroemer G
Immunity; 2013 Jul; 39(1):74-88. PubMed ID: 23890065
[TBL] [Abstract][Full Text] [Related]
12. Poxvirus-based vaccines for cancer immunotherapy: new insights from combined cytokines/co-stimulatory molecules delivery and "uncommon" strains.
Izzi V; Buler M; Masuelli L; Giganti MG; Modesti A; Bei R
Anticancer Agents Med Chem; 2014 Feb; 14(2):183-9. PubMed ID: 24237219
[TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines: a step towards prevention and treatment of cancer.
Pandey M; Mathew A; Nair MK
Eur J Surg Oncol; 1999 Apr; 25(2):209-14. PubMed ID: 10218468
[TBL] [Abstract][Full Text] [Related]
14. Development of tumour peptide vaccines: From universalization to personalization.
Ma M; Liu J; Jin S; Wang L
Scand J Immunol; 2020 Jun; 91(6):e12875. PubMed ID: 32090366
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
16. Harnessing dendritic cells in cancer.
Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
[TBL] [Abstract][Full Text] [Related]
17. [Tumor vaccines-therapeutic vaccination against cancer].
Rammensee HG; Löffler MW; Walz JS; Bokemeyer C; Haen SP; Gouttefangeas C
Internist (Berl); 2020 Jul; 61(7):690-698. PubMed ID: 32462251
[TBL] [Abstract][Full Text] [Related]
18. The dawn of vaccines for cancer prevention.
Finn OJ
Nat Rev Immunol; 2018 Mar; 18(3):183-194. PubMed ID: 29279613
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy: sipuleucel-T and beyond.
Hammerstrom AE; Cauley DH; Atkinson BJ; Sharma P
Pharmacotherapy; 2011 Aug; 31(8):813-28. PubMed ID: 21923608
[TBL] [Abstract][Full Text] [Related]
20. [Immune alterations in lung cancer - the new therapeutic approach].
Domagała-Kulawik J; Osińska I
Pneumonol Alergol Pol; 2014; 82(3):286-99. PubMed ID: 24793154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
